palmidrol has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, TH | 1 |
| Huot, P | 1 |
| Fox, SH | 1 |
| Wakefield, JD | 1 |
| Sykes, KA | 1 |
| Bartolini, WP | 1 |
| Milne, GT | 1 |
| Pearson, JP | 1 |
| Brotchie, JM | 1 |
| Esposito, E | 1 |
| Impellizzeri, D | 1 |
| Mazzon, E | 1 |
| Paterniti, I | 1 |
| Cuzzocrea, S | 1 |
2 other studies available for palmidrol and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
Topics: Amides; Amidohydrolases; Animals; Benzamides; Callithrix; Carbamates; Disease Models, Animal; Dyskin | 2011 |
Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
Topics: Amides; Animals; Astrocytes; bcl-2-Associated X Protein; Behavior, Animal; Catalepsy; Cell Membrane; | 2012 |